The abstract is read at the publisher; the summary is JClub's.
Long-term post-mitotic culture of four female human fibroblast lines recapitulates and accelerates in vivo aging, with in vitro aging matching key transcriptomic and epigenetic signatures.
- Why it matters: Aging dynamics are hard to study in humans because experimental platforms are limited, so molecularly resolved, time-based testing of anti-aging strategies is needed.
- What they did: The authors performed longitudinal paired transcriptomic and epigenetic analyses, then used direct neuronal conversion to preserve biological age and enable pseudo-longitudinal neuronal aging modeling.
- The result: In vitro aging showed a time-dependent rise in age-heterogeneity, and metformin broadly attenuated transcriptomic and epigenetic aging whereas rapamycin had limited efficacy, supporting molecular prediction of compound performance.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.